Takeda scraps late-stage amyloidosis study
FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File Photo (Reuters) – Takeda Pharmaceutical Co Ltd said on Wednesday…
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet main goals in a late-stage study in patients with moderate-to-severe…
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet main goals in a late-stage study in patients with moderate-to-severe…
BrainStorm gets FDA okay for stem cell trial in MS patients
TEL AVIV (Reuters) – BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin a clinical trial of its experimental stem cell treatment in…
Evofem shares surge as contraceptive gel meets late-stage trial goal
(Reuters) – Shares of Evofem Biosciences Inc jumped as much as 38 percent on Monday after its birth control gel showed effectiveness in a late-stage study, bringing the first hormone-free…
Johnson & Johnson’s multiple myeloma drug reduces risk of death in late-stage study
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake (Reuters) – Johnson & Johnson’s blockbuster blood cancer drug Darzalex significantly reduced…
Lilly’s diabetes drug data impresses, hurts rival Novo’s shares
(Reuters) – Eli Lilly and Co (LLY.N) said on Thursday its new two-in-one diabetes drug was successful in lowering blood sugar and reducing weight, sending its shares to a record…
Turkish lira fall: who’s responsible?: BBC News Review
US says it is ‘not responsible’ for the Turkish lira’s dramatic fall. Turkey accuses the US of ‘stabbing it in the back’. The White House says it is monitoring the…
Mersana’s cancer drug trial put on hold by FDA; shares halted
(Reuters) – Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on partial hold by the U.S. Food and Drug Administration after…
Allergan, Molecular Partners eye drug meets main goal in two studies
(Reuters) – Allergan Plc and Molecular Partners AG said on Thursday their treatment for neovascular age-related macular degeneration, a leading cause of vision loss among people over 65, met the…